Original language | English (US) |
---|---|
Pages (from-to) | 415-418 |
Number of pages | 4 |
Journal | Expert Review of Molecular Diagnostics |
Volume | 17 |
Issue number | 5 |
DOIs | |
State | Published - May 4 2017 |
Bibliographical note
Funding Information:Preparation of this article was supported by the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) and National Cancer Institute (NCI) grant #1R01HG008605 (Wolf, Clayton, Lawrenz, Principal Investigators [PIs]) and NIH, NCI/NHGRI grant #1R01CA154517 (Petersen, Koenig, Wolf, PIs); funds from the Bob Allison Ataxia Research Foundation (Thyagarajan, PI), Institute of Translational Neuroscience (Thyagarajan, PI), and Department of Laboratory Medicine and Pathology at the University of Minnesota (Thyagarajan); and NIH grant #R01NS082094 (Fogel, PI). The views expressed are those of the authors and not necessarily the views of the funders.
Keywords
- Exome sequencing
- disability
- ethics
- genomics
- neurology